265 related articles for article (PubMed ID: 6878375)
1. Clinical experience with Fluosol-DA.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
[TBL] [Abstract][Full Text] [Related]
2. Fluosol-DA as a red-cell substitute in acute anemia.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
[TBL] [Abstract][Full Text] [Related]
3. Red cell substitutes: hemoglobin solution or fluorocarbon?
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Rice CL; Moss GS
J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
[TBL] [Abstract][Full Text] [Related]
4. Canadian Red Cross lecture. Current concepts of oxygen-transporting blood substitutes.
Bolin RB
Can J Surg; 1982 Jul; 25(4):422-4. PubMed ID: 7046893
[TBL] [Abstract][Full Text] [Related]
5. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
Ishikawa R; Peerless SJ; Hunter IG
No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
[TBL] [Abstract][Full Text] [Related]
6. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
Swann KW; Ropper AH; Zervas NT
Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with Fluosol-DA (20%) in the United States.
Tremper KK; Levine EM; Waxman K
Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
[No Abstract] [Full Text] [Related]
8. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
Suyama T; Yokoyama K; Naito R
Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
[TBL] [Abstract][Full Text] [Related]
10. Present status of clinical studies of Fluosol-DA (20%) in Japan.
Mitsuno T; Ohyanagi H
Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
[TBL] [Abstract][Full Text] [Related]
11. Initial Canadian experience with artificial blood (Fluosol-DA-20%) in severely anemic patients.
Stefaniszyn HJ; Wynands JE; Salerno TA
J Cardiovasc Surg (Torino); 1985; 26(4):337-42. PubMed ID: 4019576
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience of hemodilution with fluosol-DA (author's transl)].
Fukushima K; Nakamura M; Takemura R
Masui; 1981 Jul; 30(7):741-5. PubMed ID: 7321165
[No Abstract] [Full Text] [Related]
13. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.
Tremper KK; Friedman AE; Levine EM; Lapin R; Camarillo D
N Engl J Med; 1982 Jul; 307(5):277-83. PubMed ID: 7045667
[TBL] [Abstract][Full Text] [Related]
14. Use of Fluosol-DA during open-heart surgery.
Engelman RM; Dobbs WA; Rousou JH; Anisimowicz L
Prog Clin Biol Res; 1983; 122():273-82. PubMed ID: 6878370
[TBL] [Abstract][Full Text] [Related]
15. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
Tremper KK; Anderson ST
Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
[TBL] [Abstract][Full Text] [Related]
16. Rationale for the clinical studies of anemia treated with the perfluorochemical emulsion: Fluosol DA 20%.
Tremper KK
Prog Clin Biol Res; 1983; 122():307-13. PubMed ID: 6348785
[No Abstract] [Full Text] [Related]
17. New treatment of cerebral vasospasm with Fluosol-DA 20%: protective effect on cerebral ischemia and change of cerebral blood flow (CBF).
Handa H; Nagasawa S; Yonekawa Y; Naruo Y; Oda Y
Prog Clin Biol Res; 1983; 122():299-306. PubMed ID: 6878374
[TBL] [Abstract][Full Text] [Related]
18. Fluosol-DA as a red-cell substitute in acute anemia.
N Engl J Med; 1986 Dec; 315(26):1677-8. PubMed ID: 3785341
[No Abstract] [Full Text] [Related]
19. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
[TBL] [Abstract][Full Text] [Related]
20. [Possibility of the use of perfluorochemicals (fluorocarbons) as adjuvants in chemotherapy of cancer].
Kuwamura K; Kokunai T
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1256-61. PubMed ID: 7184453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
